Evidence map›Paper›PMID 12507413›Full record

ReviewCurrent neurology and neuroscience reports2003

Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy.

David S Saperstein, Richard J Barohn

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current neurology and neuroscience reports, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

David S SapersteinDepartment of Neurology, The University of Kansas Medical Center, 1005B Wescoe, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA. dsaperstein@kumc.edu
Richard J Barohn
University of Kansas Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired, immune-mediated demyelinating neuropathy. It is the most common treatable acquired polyneuropathy and represents a significant number of initially undiagnosed neuropathy patients. This article reviews the common clinical, laboratory, and electrodiagnostic features of CIDP. In addition, current areas of uncertainty are discussed.

Indexed as

Polyradiculoneuropathy, Chronic Inflammatory DemyelinatingAdrenal Cortex HormonesClinical Trials as TopicElectrophysiologyHumansImmunoglobulins, IntravenousPlasma ExchangeRisk FactorsTreatment OutcomeAdrenal Cortex HormonesImmunoglobulins, Intravenous

Identifiers

PMID12507413
OpenAlexW2026414812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.